NVO

$0.00

(

0.00%

)
Quote details

stock

Novo Nordisk A/S

NYSE | NVO

55.61

USD

$0.00

(

0.00%

)

At Close (As of Sep 26, 2025)

$252.44B

Market Cap

14.19

P/E Ratio

3.95

EPS

$117.32

52 Week High

$44.54

52 Week Low

HEALTHCARE

Sector

NVO Chart

Recent Chart
Price Action

NVO Technicals

Tags:

NVO Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (DKK)
Gross Profit $246B
Total Revenue $290B
Cost Of Revenue $45B
Costof Goods And Services Sold $45B
Operating Income $128B
Selling General And Administrative $5.3B
Research And Development $48B
Operating Expenses $118B
Investment Income Net -
Net Interest Income -$91M
Interest Income $1.8B
Interest Expense $1.6B
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8.5B
Income Before Tax $127B
Income Tax Expense $26B
Interest And Debt Expense -
Net Income From Continuing Operations $101B
Comprehensive Income Net Of Tax -
Ebit $129B
Ebitda $137B
Net Income $101B

Revenue & Profitability

Earnings Performance

NVO Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (DKK)
Total Assets $466B
Total Current Assets $161B
Cash And Cash Equivalents At Carrying Value $16B
Cash And Short Term Investments $16B
Inventory $41B
Current Net Receivables $87B
Total Non Current Assets $305B
Property Plant Equipment $162B
Accumulated Depreciation Amortization Ppe -
Intangible Assets $91B
Intangible Assets Excluding Goodwill $91B
Goodwill $20B
Investments -
Long Term Investments $2.7B
Short Term Investments $11B
Other Current Assets $6.3B
Other Non Current Assets -
Total Liabilities $322B
Total Current Liabilities $218B
Current Accounts Payable $29B
Deferred Revenue -
Current Debt -
Short Term Debt $13B
Total Non Current Liabilities $105B
Capital Lease Obligations $6.8B
Long Term Debt $84B
Current Long Term Debt $12B
Long Term Debt Noncurrent -
Short Long Term Debt Total $103B
Other Current Liabilities $166B
Other Non Current Liabilities $23M
Total Shareholder Equity $143B
Treasury Stock -
Retained Earnings $144B
Common Stock $446M
Common Stock Shares Outstanding $4.5B

yearly Cash Flow (As of Dec 31, 2024)

Field Value (DKK)
Operating Cashflow $121B
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $8.5B
Capital Expenditures $51B
Change In Receivables -
Change In Inventory -$9B
Profit Loss -
Cashflow From Investment -$129B
Cashflow From Financing $8.7B
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $44B
Dividend Payout Common Stock $44B
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$20B
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $101B

yearly Income Statement (As of Dec 31, 2024)

Field Value (DKK)
Gross Profit $246B
Total Revenue $290B
Cost Of Revenue $45B
Costof Goods And Services Sold $45B
Operating Income $128B
Selling General And Administrative $5.3B
Research And Development $48B
Operating Expenses $118B
Investment Income Net -
Net Interest Income -$91M
Interest Income $1.8B
Interest Expense $1.6B
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8.5B
Income Before Tax $127B
Income Tax Expense $26B
Interest And Debt Expense -
Net Income From Continuing Operations $101B
Comprehensive Income Net Of Tax -
Ebit $129B
Ebitda $137B
Net Income $101B

Dividends

Field Value
Ex Dividend Date 2025-08-18
Declaration Date 2025-08-06
Record Date 2025-08-18
Payment Date 2025-08-26
Amount 0.584816

NVO News

NVO Profile

Novo Nordisk A/S Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - GENERAL

Novo Nordisk A/S is a leading global healthcare company based in Bagsvaerd, Denmark, specializing in the development and manufacturing of pharmaceuticals, particularly in the fields of diabetes care, obesity treatment, and hormone replacement therapy. With a strong focus on innovation and sustainability, Novo Nordisk leverages advanced biotechnology and scientific research to deliver effective solutions for chronic diseases. As a key player in the biopharmaceutical industry, the company is committed to improving patient outcomes while maintaining responsible business practices.

DVLT
+30.57%
$1.09
INTC
+8.87%
$33.99
GPUS
+19.56%
$0.45
CGBS
-39.47%
$0.03
NVDA
+0.40%
$177.69
SNAP
-0.78%
$8.26
NUAI
+33.33%
$1.84
CJET
+10.63%
$0.17
F
+3.39%
$12.01
DNN
-3.14%
$2.77
PSTV
+9.60%
$0.61
APLT
+121.34%
$1.24
TSLA
+4.01%
$440.40
RGTI
-2.86%
$31.18
BIAF
+55.13%
$5.29
YAAS
-8.19%
$0.09
PLUG
+0.42%
$2.37
CIFR
-1.62%
$11.47
NIO
+4.91%
$7.47
ADAP
+15.74%
$0.14
AAL
-0.70%
$11.31
WOK
-5.22%
$0.08
NEHC
+49.83%
$1.38
RIG
+0.79%
$3.18
IONZ
+5.83%
$4.34
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
BBD
-2.09%
$3.27
MRM
+102.75%
$2.94
QBTS
+1.55%
$26.75
VALE
-1.74%
$10.70
IREN
-9.57%
$41.86
BTG
+1.54%
$4.92
BLMZ
+12.51%
$0.20
QUBT
-2.11%
$20.14
LYT
-16.77%
$0.09
AMZN
-0.93%
$218.15
MARA
+0.37%
$16.13
KVUE
+1.54%
$16.42
CAN
-10.64%
$0.79
RIOT
+5.67%
$17.69
KDLY
+7.69%
$1.26
RXRX
-5.12%
$4.63
AAPL
-0.54%
$255.46
ATCH
-4.22%
$0.79
SOUN
-2.50%
$15.94
PLTR
-0.86%
$177.57
BITF
-5.22%
$2.54
TLRY
-3.36%
$1.14
FCX
+1.14%
$35.74
BMNR
+1.69%
$50.41
QS
+0.08%
$12.50
RMBL
+60.50%
$3.21
BURU
-3.83%
$0.13
ETHD
-5.95%
$3.95
IXHL
-0.01%
$0.59
SHOT
+12.24%
$0.28
GRAB
-2.24%
$6.11
ADD
-25.47%
$0.05
RR
+2.68%
$4.20
CLSK
-5.32%
$13.68
RIVN
-0.95%
$15.59
SOFI
-0.49%
$27.98
ONDS
-1.16%
$7.66
CVE
+0.36%
$17.76
RAYA
-3.15%
$0.04
SRM
+53.27%
$10.30
PFE
+0.65%
$23.75
ACHR
-0.53%
$9.27
BULL
+2.35%
$14.98
IONQ
-3.09%
$67.28
BB
+6.34%
$4.94
JOBY
+1.63%
$16.12
NOK
-0.53%
$4.65
AMD
-1.12%
$159.46
CRWV
-4.98%
$120.34
CLF
+2.52%
$12.37
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BTE
+2.64%
$2.52
WBD
-0.82%
$19.61
WLGS
-5.57%
$0.04
HIMS
+6.39%
$58.38
ABEV
+0.21%
$2.30
AQMS
+48.37%
$7.30
MRVL
-0.76%
$83.17
ETWO
0.00%
$3.30
ORCL
-2.70%
$283.45
AG
+4.15%
$12.15
HOOD
-0.70%
$121.78
AIIO
-15.63%
$2.04
SDM
-86.40%
$1.85
OKLO
-7.21%
$110.53
ITUB
+0.55%
$7.24
MU
+0.28%
$157.27
AFMD
-34.94%
$0.18
AGNC
+0.81%
$9.84
SMCI
-0.90%
$45.82
WAI
+47.78%
$4.67
HBAN
+0.72%
$17.44
DVLT
+30.57%
$1.09
INTC
+8.87%
$33.99
GPUS
+19.56%
$0.45
CGBS
-39.47%
$0.03
NVDA
+0.40%
$177.69
SNAP
-0.78%
$8.26
NUAI
+33.33%
$1.84
CJET
+10.63%
$0.17
F
+3.39%
$12.01
DNN
-3.14%
$2.77
PSTV
+9.60%
$0.61
APLT
+121.34%
$1.24
TSLA
+4.01%
$440.40
RGTI
-2.86%
$31.18
BIAF
+55.13%
$5.29
YAAS
-8.19%
$0.09
PLUG
+0.42%
$2.37
CIFR
-1.62%
$11.47
NIO
+4.91%
$7.47
ADAP
+15.74%
$0.14
AAL
-0.70%
$11.31
WOK
-5.22%
$0.08
NEHC
+49.83%
$1.38
RIG
+0.79%
$3.18
IONZ
+5.83%
$4.34
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
BBD
-2.09%
$3.27
MRM
+102.75%
$2.94
QBTS
+1.55%
$26.75
VALE
-1.74%
$10.70
IREN
-9.57%
$41.86
BTG
+1.54%
$4.92
BLMZ
+12.51%
$0.20
QUBT
-2.11%
$20.14
LYT
-16.77%
$0.09
AMZN
-0.93%
$218.15
MARA
+0.37%
$16.13
KVUE
+1.54%
$16.42
CAN
-10.64%
$0.79
RIOT
+5.67%
$17.69
KDLY
+7.69%
$1.26
RXRX
-5.12%
$4.63
AAPL
-0.54%
$255.46
ATCH
-4.22%
$0.79
SOUN
-2.50%
$15.94
PLTR
-0.86%
$177.57
BITF
-5.22%
$2.54
TLRY
-3.36%
$1.14
FCX
+1.14%
$35.74
BMNR
+1.69%
$50.41
QS
+0.08%
$12.50
RMBL
+60.50%
$3.21
BURU
-3.83%
$0.13
ETHD
-5.95%
$3.95
IXHL
-0.01%
$0.59
SHOT
+12.24%
$0.28
GRAB
-2.24%
$6.11
ADD
-25.47%
$0.05
RR
+2.68%
$4.20
CLSK
-5.32%
$13.68
RIVN
-0.95%
$15.59
SOFI
-0.49%
$27.98
ONDS
-1.16%
$7.66
CVE
+0.36%
$17.76
RAYA
-3.15%
$0.04
SRM
+53.27%
$10.30
PFE
+0.65%
$23.75
ACHR
-0.53%
$9.27
BULL
+2.35%
$14.98
IONQ
-3.09%
$67.28
BB
+6.34%
$4.94
JOBY
+1.63%
$16.12
NOK
-0.53%
$4.65
AMD
-1.12%
$159.46
CRWV
-4.98%
$120.34
CLF
+2.52%
$12.37
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BTE
+2.64%
$2.52
WBD
-0.82%
$19.61
WLGS
-5.57%
$0.04
HIMS
+6.39%
$58.38
ABEV
+0.21%
$2.30
AQMS
+48.37%
$7.30
MRVL
-0.76%
$83.17
ETWO
0.00%
$3.30
ORCL
-2.70%
$283.45
AG
+4.15%
$12.15
HOOD
-0.70%
$121.78
AIIO
-15.63%
$2.04
SDM
-86.40%
$1.85
OKLO
-7.21%
$110.53
ITUB
+0.55%
$7.24
MU
+0.28%
$157.27
AFMD
-34.94%
$0.18
AGNC
+0.81%
$9.84
SMCI
-0.90%
$45.82
WAI
+47.78%
$4.67
HBAN
+0.72%
$17.44

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.